N/A
Completed N=152
Post Market Surveillance Study of the Wingspan Stent System
Intracranial Atherosclerosis
Source: ClinicalTrials.gov NCT02034058 ↗
Enrolled (actual)
152
Serious AEs
5.9%
Results posted
Dec 2019
Primary outcomePrimary: Rate of Stroke or Death Among Participants — 4 Participants
Summary
The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate of Stroke or Death Among Participants |
4 | — |
| SECONDARY Rate of Ischemic Stroke Among Participants |
1 | — |
| SECONDARY Rate of Neurological Death Among Participants |
2 | — |
| SECONDARY Rate of Stroke Recovery Among Participants |
— | — |
| SECONDARY Rate of Stroke in the Territory of the Stented Artery Among Participants |
4 | — |
Eligibility Criteria
All patients for whom treatment with the Wingspan Stent System is considered.
Data sourced from ClinicalTrials.gov (NCT02034058). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.